Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTavistock Regulatory News (TAVI)

Share Price Information for Tavistock (TAVI)

Share Price is delayed by 15 minutes
Get Live Data
3.15    0.00 (0.00%)
Bid:
3.00
Ask:
3.30
Spread: 0.30 (10.00%)
Market Cap: £13.89m
TAVI Live PriceLast checked at - London Stock Exchange

Intraday Tavistock Share Chart

Trading Update

24 Jun 2020 07:00

RNS Number : 8456Q
Tavistock Investments PLC
24 June 2020
 

Tavistock Investments Plc

("Tavistock" or the "Company")

Trading Update

24 June 2020

The Company is pleased to update the market that trading during the first two months of the financial year has been ahead of the Board's expectations. This is due both to the swift action taken to mitigate the impact of COVID-19 and the performance of the Tavistock ACUMEN Protection Portfolios.

Rapid adoption of new technology-based work practices, and implementation of business continuity plans, enabled the entire Group to move to home-based working while cost reductions were made. Voluntary salary waivers by all senior management and the significant majority of other staff, together with use of the Government's furlough scheme, mean the company has continued to trade profitably during lockdown.

The strong performance of Tavistock's ACUMEN Protection Portfolios has contributed significantly to this success. Designed specifically to shield clients from sharp and sustained falls in financial markets, they feature an automated algorithmic safeguard. If markets fall, as volatility increases, the algorithm triggers movement out of investment assets and into cash; when markets recover, as volatility decreases, the reverse is triggered, with cash being gradually reinvested into higher risk assets. These funds perform particularly well when used as a bond substitute within clients' investment portfolios.

The newest fund, the ACUMEN ESG Protection Portfolio, has performed particularly effectively since its launch on 5 December 2019, with its NAV (net asset value) having declined by less than 1%. Morgan Stanley & Co International Plc provides the ESG Protection Portfolio with its protection level, set at 90% of its NAV's highest ever value. This protection enables investors to both limit their downside exposure, and lock in 90% of performance upside.

Brian Raven, Chief Executive, said: "The performance of the ACUMEN Protection Portfolios has been exceptional, underpinning the profitability of the Group's investment management business. Our advisory business has also performed particularly well, stepping up to support clients in these challenging times and to mitigate the adverse effect that the lockdown is having on new business.

I have been enormously encouraged by the way that our entire workforce has risen to the challenges arising from the pandemic and by the widespread adoption of the Protection Portfolios to safeguard clients' personal wealth in these uncertain times.

The COVID-19 crisis triggered the biggest and fastest fall in markets since 1929 and we are now facing the worst recession in hundreds of years. Historically, viral pandemics have come in waves, so our Protection Portfolios seem to be the ideal choice right now, for the many retail clients worried about further, severe market shocks.

The Board maintains its focus on tight financial management and is confident the business will emerge from the current crisis in good shape."

Ends

Enquiries

Tavistock Investments Plc

Oliver Cooke

Brian Raven

Tel: 01753 867000

 

Arden Partners Plc

Paul Shackleton

Tel: 020 7614 5900

Allenby Capital Limited

Nick Naylor

Nick Athanas

Tel: 020 3328 5656

Vested

Sophie Paterson

Tel: 07540 496 159

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTFLFEERSIVFII
Date   Source Headline
29th May 20269:00 amRNSDirectorate Change
2nd Apr 20267:00 amRNSCompletion of Acquisition
30th Mar 20262:55 pmRNSChange of Auditor
5th Feb 20267:00 amRNSFurther Update on Litigation with Titan
20th Jan 20267:00 amRNSAppointment of Nominated Adviser and Broker
23rd Dec 20257:00 amRNSInterim Results
23rd Dec 20257:00 amRNSInterim Results
17th Dec 202512:13 pmRNSFurther update re ongoing litigation with Titan
16th Dec 20257:00 amRNSUpdate re ongoing litigation with Titan
6th Nov 202512:00 pmRNSResult of AGM
2nd Oct 20257:00 amRNSUpdate re ongoing litigation
30th Sep 20255:00 pmRNSTotal Voting Rights
30th Sep 20257:00 amRNSNotice of AGM
25th Sep 20257:00 amRNSTransfer of Shares from treasury to EBT and TVR
24th Sep 202510:57 amRNSDirector/PDMR Shareholding
18th Sep 20257:00 amRNSFinal Results for the Year Ended 31 March 2025
15th Sep 20252:08 pmRNSHolding(s) in Company
11th Sep 20257:00 amRNSStrategic refocus and acquisition of Lifetime
7th Jul 202512:40 pmRNSDirector / PDMR Dealing
8th Apr 20254:15 pmRNSDirector/PDMR Shareholding
12th Mar 20257:00 amRNSTransaction in Own Shares
28th Feb 20255:00 pmRNSTotal Voting Rights
20th Feb 20257:00 amRNSCompletion of acquisition of Alpha Beta Partners
14th Feb 202512:08 pmRNSDirector/PDMR Shareholding
11th Feb 20257:00 amRNSTransaction in Own Shares,Director Dealing and TVR
6th Feb 20252:16 pmRNSDirector/PDMR Shareholding
30th Jan 202511:00 amRNSHolding(s) in Company
30th Jan 20259:53 amRNSHolding(s) in Company
6th Jan 202511:54 amRNSHolding(s) in Company
2nd Jan 20255:45 pmRNSTotal Voting Rights - Replacement
31st Dec 20241:30 pmRNSTotal Voting Rights
12th Dec 202412:00 pmRNSTransaction in Own Shares and Total Voting Rights
11th Dec 202411:30 amRNSResult of AGM
9th Dec 202412:49 pmRNSTransaction in Own Shares and Total Voting Rights
9th Dec 20247:00 amRNSInterim Results
2nd Dec 20247:00 amRNSRepositioning of Retail Asset Management business
22nd Nov 20247:00 amRNSStrategic acquisition and completion of disposal
11th Nov 20243:38 pmRNSNotice of AGM
30th Oct 202411:25 amRNSResult of General Meeting
2nd Oct 20243:50 pmRNSPublication of Circular and Notice of GM
2nd Oct 202411:32 amRNSDirector/PDMR Shareholding
1st Oct 20247:00 amRNSProposed disposals for up to £37.75 million
30th Sep 20247:00 amRNSFinal Results for the Year Ended 31 March 2024
19th Sep 20242:47 pmRNSUpdate on Titan Dispute
11th Jul 20247:00 amRNSFollow up to Titan termination announcement
8th Jul 20244:19 pmRNSTermination of strategic partnership
28th Jun 202410:16 amRNSStatement re press speculation
21st Jun 202410:31 amRNSDirectorate Change
31st May 20247:00 amRNSBoard role change
8th Jan 20247:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.